Cargando…
Surgical Management of Retroperitoneal Sarcoma
Surgery is the cornerstone of treatment for retroperitoneal sarcoma (RPS). Surgery should be performed by a surgical oncologist with sub-specialization in this disease and in the context of a multidisciplinary team of sarcoma specialists. For primary RPS, the goal of surgery is to achieve the comple...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217420/ https://www.ncbi.nlm.nih.gov/pubmed/37232807 http://dx.doi.org/10.3390/curroncol30050349 |
_version_ | 1785048533444853760 |
---|---|
author | Dominguez, Dana A. Sampath, Sagus Agulnik, Mark Liang, Yu Nguyen, Bao Trisal, Vijay Melstrom, Laleh G. Lewis, Aaron G. Paz, Isaac Benjamin Roberts, Randall F. Tseng, William W. |
author_facet | Dominguez, Dana A. Sampath, Sagus Agulnik, Mark Liang, Yu Nguyen, Bao Trisal, Vijay Melstrom, Laleh G. Lewis, Aaron G. Paz, Isaac Benjamin Roberts, Randall F. Tseng, William W. |
author_sort | Dominguez, Dana A. |
collection | PubMed |
description | Surgery is the cornerstone of treatment for retroperitoneal sarcoma (RPS). Surgery should be performed by a surgical oncologist with sub-specialization in this disease and in the context of a multidisciplinary team of sarcoma specialists. For primary RPS, the goal of surgery is to achieve the complete en bloc resection of the tumor along with involved organs and structures to maximize the clearance of the disease. The extent of resection also needs to consider the risk of complications. Unfortunately, the overarching challenge in primary RPS treatment is that even with optimal surgery, tumor recurrence occurs frequently. The pattern of recurrence after surgery (e.g., local versus distant) is strongly associated with the specific histologic type of RPS. Radiation and systemic therapy may improve outcomes in RPS and there is emerging data studying the benefit of non-surgical treatments in primary disease. Topics in need of further investigation include criteria for unresectability and management of locally recurrent disease. Moving forward, global collaboration among RPS specialists will be key for continuing to advance our understanding of this disease and find more effective treatments. |
format | Online Article Text |
id | pubmed-10217420 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102174202023-05-27 Surgical Management of Retroperitoneal Sarcoma Dominguez, Dana A. Sampath, Sagus Agulnik, Mark Liang, Yu Nguyen, Bao Trisal, Vijay Melstrom, Laleh G. Lewis, Aaron G. Paz, Isaac Benjamin Roberts, Randall F. Tseng, William W. Curr Oncol Review Surgery is the cornerstone of treatment for retroperitoneal sarcoma (RPS). Surgery should be performed by a surgical oncologist with sub-specialization in this disease and in the context of a multidisciplinary team of sarcoma specialists. For primary RPS, the goal of surgery is to achieve the complete en bloc resection of the tumor along with involved organs and structures to maximize the clearance of the disease. The extent of resection also needs to consider the risk of complications. Unfortunately, the overarching challenge in primary RPS treatment is that even with optimal surgery, tumor recurrence occurs frequently. The pattern of recurrence after surgery (e.g., local versus distant) is strongly associated with the specific histologic type of RPS. Radiation and systemic therapy may improve outcomes in RPS and there is emerging data studying the benefit of non-surgical treatments in primary disease. Topics in need of further investigation include criteria for unresectability and management of locally recurrent disease. Moving forward, global collaboration among RPS specialists will be key for continuing to advance our understanding of this disease and find more effective treatments. MDPI 2023-04-29 /pmc/articles/PMC10217420/ /pubmed/37232807 http://dx.doi.org/10.3390/curroncol30050349 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Dominguez, Dana A. Sampath, Sagus Agulnik, Mark Liang, Yu Nguyen, Bao Trisal, Vijay Melstrom, Laleh G. Lewis, Aaron G. Paz, Isaac Benjamin Roberts, Randall F. Tseng, William W. Surgical Management of Retroperitoneal Sarcoma |
title | Surgical Management of Retroperitoneal Sarcoma |
title_full | Surgical Management of Retroperitoneal Sarcoma |
title_fullStr | Surgical Management of Retroperitoneal Sarcoma |
title_full_unstemmed | Surgical Management of Retroperitoneal Sarcoma |
title_short | Surgical Management of Retroperitoneal Sarcoma |
title_sort | surgical management of retroperitoneal sarcoma |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217420/ https://www.ncbi.nlm.nih.gov/pubmed/37232807 http://dx.doi.org/10.3390/curroncol30050349 |
work_keys_str_mv | AT dominguezdanaa surgicalmanagementofretroperitonealsarcoma AT sampathsagus surgicalmanagementofretroperitonealsarcoma AT agulnikmark surgicalmanagementofretroperitonealsarcoma AT liangyu surgicalmanagementofretroperitonealsarcoma AT nguyenbao surgicalmanagementofretroperitonealsarcoma AT trisalvijay surgicalmanagementofretroperitonealsarcoma AT melstromlalehg surgicalmanagementofretroperitonealsarcoma AT lewisaarong surgicalmanagementofretroperitonealsarcoma AT pazisaacbenjamin surgicalmanagementofretroperitonealsarcoma AT robertsrandallf surgicalmanagementofretroperitonealsarcoma AT tsengwilliamw surgicalmanagementofretroperitonealsarcoma |